Showing 1 - 10 results of 10 for search 'Ya. V. Vlasov', query time: 0.03s
Refine Results
-
1
-
2
Current requirements for studies of drugs for the pathogenetic treatment of multiple sclerosis by A. N. Boyko, N. N. Spirin, Ya. V. Vlasov, M. N. Zakharova
Published 2019-12-01
Article -
3
-
4
-
5
Results of Expert Council meeting on modern principles of treatment optimization in patients with relapsing-remitting multiple sclerosis using anti-CD20 monoclonal antibody by A. N. Boyko, N. V. Khachanova, D. S. Korobko, D. S. Kasatkin, Ya. V. Vlasov, E. P. Evdoshenko, E. V. Popova, K. Z. Bakhtiyarova, S. A. Sivertseva
Published 2021-06-01
Article -
6
-
7
-
8
Clinical recommendations for the use of ocrelizumab in patients with multiple sclerosis by A. N. Boyko, M. V. Davydovskaya, N. V. Khachanova, M. N. Zakharova, N. N. Spirin, E. V. Popova, V. M. Alifirova, Ya. V. Vlasov, S. A. Sivertseva, F. A. Khabirov, M. V. Shumilina, E. P. Evdoshenko
Published 2019-11-01
Article -
9
Recommendations for the use of cladribine tablets for the pathogenetic treatment of patients with highly active multiple sclerosis by K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. V. Davydovskaya, M. N. Zakharova, N. A. Malkova, A. I. Nilov, S. A. Sivertseva, N. N. Spirin, N. A. Totolyan, F. A. Khabirov, M. V. Shumilina
Published 2020-06-01
Article -
10
Recommendations for switching patients with highly active multiple sclerosis from other disease modifying drugs for multiple sclerosis to cladribine tablets by N. A. Totolyan, V. M. Alifirova, K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. N. Zakharova, D. S. Kasatkin, S. V. Kotov, A. I. Nilov, S. A. Sivertseva, A. A. Sokolova, N. N. Spirin, F. A. Khabirov, D. Paradnika
Published 2020-10-01
Article